Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.
Clinical trial NCT03735966 · COMPLETED
Trial details
- NCT number
- NCT03735966
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-10-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.